Eiasi Expands In US

To read the full article, please choose one of the following options:

North America has became Japanese drugmaker Eisai 's largest market last year with sales reaching JPY303.4bn (US$2.5bn), around 45% of total turnover. The strong performance was driven by surging demand for leading products such as Alzheimer's drug Aricept (donepezil) and ulcer treatment Aciphex (rabeprazole).